Colon cancer diagnosis and therapy. Volume 1 / Ganji Purnachandra Nagaraju, Dhananjay Shukla, Naveen Kumar Vishvakarma, editors.
Nagaraju, Ganji Purnachandra, editor.; Shukla, Dhananjay, editor.; Vishvakarma, Naveen Kumar, editor.
2021
RC280.C6 .C65 2021
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Colon cancer diagnosis and therapy. Volume 1 / Ganji Purnachandra Nagaraju, Dhananjay Shukla, Naveen Kumar Vishvakarma, editors.
ISBN
9783030633691 (electronic bk.)
3030633691 (electronic bk.)
9783030633684
3030633683
DOI
https://doi.org/10.1007/978-3-030-63369-1
Published
Cham : Springer, [2021]
Copyright
©2021
Language
English
Description
1 online resource : color illustrations
Item Number
10.1007/978-3-030-63369-1 doi
Call Number
RC280.C6 .C65 2021
Dewey Decimal Classification
616.99/4347
Summary
Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the first of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage also addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutic, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.
Note
Includes index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed June 16, 2021).
Added Author
Nagaraju, Ganji Purnachandra, editor.
Shukla, Dhananjay, editor.
Vishvakarma, Naveen Kumar, editor.
Available in Other Form
Colon cancer diagnosis and therapy. Volume 1.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Epidimology of colorectal cancer
Colorectal cancer: A model for the study of cancer immunology
Impact of Covid-19 Pandemic on Gastro Intestinal Cancer Patients: An Emphasis on Colorectal Cancer
Potential role of NMR and MRI in colon cancer
Role of micro-RNA in-situ hybridization in colon cancer diagnosis
Role of epigenetics in colorectal cancer
Exosomal biomarkers in colorectal cancer
Biomarkers as putative therapeutic targets in colorectal cancer
Proteins involved in colorectal cancer: Identification strategies and possible roles
Short-chain fatty acids as therapeutic agents in colon malignancies
Targeting of angiogenesis for colorectal cancer therapy
Antiinflammatory molecular mechanism and contribution of drug transport molecules in colorectal cancer cells
Emerging role of circulating tumour DNA in treatment response prognosis in colon cancer
Immuno-modulating mediators of colon cancer as immunotherapeutic: mechanism and potential
Immune checkpoint inhibitors as armor for targeted immunotherapy of colorectal cancer
Examining the role of the MACC1 gene in colorectal cancer metastasis
Index.

Browse Subjects

Show more subjects...

Statistics

from
to
Export